{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2024,5,19]],"date-time":"2024-05-19T00:49:38Z","timestamp":1716079778057},"reference-count":31,"publisher":"Ovid Technologies (Wolters Kluwer Health)","issue":"11","content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2013,11]]},"DOI":"10.1097\/ico.0b013e3182a3655d","type":"journal-article","created":{"date-parts":[[2013,9,20]],"date-time":"2013-09-20T09:04:33Z","timestamp":1379667873000},"page":"1465-1469","source":"Crossref","is-referenced-by-count":2,"title":["Comparison of the Effects of Topical Cyclosporine A 0.05%, Cyclosporine A 2%, Epinastine Hydrochloride 0.05%, and Prednisolone Acetate 1% on Allergic Inflammation in an Experimental Allergic Conjunctivitis Model"],"prefix":"10.1097","volume":"32","author":[{"given":"Bilak","family":"Semsettin","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Emre","family":"Sinan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Vardi","family":"Nigar","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"276","reference":[{"key":"R1-12-20210204","doi-asserted-by":"crossref","first-page":"1101","DOI":"10.1046\/j.1398-9995.2003.00326.x","article-title":". Animal models of allergic and inflammatory conjunctivitis.","volume":"58","author":"Groneberg","year":"2003","journal-title":"Allergy"},{"key":"R2-12-20210204","doi-asserted-by":"crossref","first-page":"477","DOI":"10.1097\/00130832-200110000-00015","article-title":"Advances in ocular allergy: basic mechanisms, clinical patterns and new therapies.","volume":"1","author":"Solomon","year":"2001","journal-title":"Curr Opin Allergy Clin Immunol"},{"key":"R3-12-20210204","doi-asserted-by":"crossref","first-page":"105","DOI":"10.1097\/01.iio.0000212135.77675.6a","article-title":"Topical cyclosporine for treatment of ocular surface disease.","volume":"46","author":"Foulks","year":"2006","journal-title":"Int Ophthalmol Clin"},{"key":"R4-12-20210204","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1016\/S0181-5512(07)91357-1","article-title":". Efficacy of topical 2 cyclosporine A as a steroid-sparing agent in steroid-dependent vernal keratoconjunctivitis in French.","volume":"30","author":"Doan","year":"2007","journal-title":"J Fr Ophtalmol"},{"key":"R5-12-20210204","doi-asserted-by":"crossref","first-page":"693","DOI":"10.3129\/i06-061","article-title":"Topical 2 cyclosporine A in preservative-free artificial tears for the treatment of vernal keratoconjunctivitis.","volume":"41","author":"Kilic","year":"2006","journal-title":"Can J Ophthalmol"},{"key":"R6-12-20210204","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1007\/s00347-001-0600-y","article-title":". Cyclosporin A 2 eyedrops in therapy of atopic and vernal keratoconjunctivitis in German.","volume":"99","author":"Tomida","year":"2002","journal-title":"Ophthalmologe"},{"key":"R7-12-20210204","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1159\/000050876","article-title":". Cyclosporine effects on clinical findings and impression cytology specimens in severe vernal keratoconjunctivitis.","volume":"215","author":"Avunduk","year":"2001","journal-title":"Ophthalmologica"},{"key":"R8-12-20210204","doi-asserted-by":"crossref","first-page":"1715","DOI":"10.1016\/S0161-6420(98)99043-1","article-title":". A randomized, placebo-controlled trial of topical cyclosporin A in steroid-dependent atopic keratoconjunctivitis.","volume":"105","author":"Hingorani","year":"1998","journal-title":"Ophthalmology"},{"key":"R9-12-20210204","doi-asserted-by":"crossref","first-page":"1035","DOI":"10.1097\/ICO.0b013e31812dfab3","article-title":"Management of severe allergic conjunctivitis with topical cyclosporin a 0.05 eyedrops.","volume":"26","author":"Ozcan","year":"2007","journal-title":"Cornea"},{"key":"R10-12-20210204","doi-asserted-by":"crossref","first-page":"476","DOI":"10.1016\/j.ophtha.2003.05.035","article-title":". A randomized trial of topical cyclosporin 0.05 in topical steroid-resistant atopic keratoconjunctivitis.","volume":"111","author":"Akpek","year":"2004","journal-title":"Ophthalmology"},{"key":"R11-12-20210204","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1007\/s10384-008-0577-z","article-title":". Efficacy of topical cyclosporin A 0.05 in conjunctival impression cytology specimens and clinical findings of severe vernal keratoconjunctivitis in children.","volume":"52","author":"Keklikci","year":"2008","journal-title":"Jpn J Ophthalmol"},{"key":"R12-12-20210204","first-page":"365","article-title":". Antiallergic effect of epinastine: the elucidation of the mechanism.","volume":"39","author":"Tasaka","year":"1990","journal-title":"Pharmacometrics"},{"key":"R13-12-20210204","doi-asserted-by":"crossref","first-page":"33","DOI":"10.2165\/00002018-200225010-00004","article-title":"Locally administered ocular corticosteroids: benefits and risks.","volume":"25","author":"McGhee","year":"2002","journal-title":"Drug Saf"},{"key":"R14-12-20210204","doi-asserted-by":"crossref","first-page":"631","DOI":"10.1006\/exer.1997.0362","article-title":". The role of cellular immunity both in the induction and effector phases of experimental allergic blepharoconjunctivitis (EAC) in rats.","volume":"65","author":"Fukushima","year":"1997","journal-title":"Exp Eye Res"},{"key":"R15-12-20210204","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1076\/ceyr.18.2.117.5383","article-title":". Genetic background determines the nature of immune responses and experimental immune-mediated blepharoconjunctivitis (EC).","volume":"18","author":"Yoshida","year":"1999","journal-title":"Curr Eye Res"},{"key":"R16-12-20210204","doi-asserted-by":"crossref","first-page":"119","DOI":"10.1159\/000068551","article-title":". Comparison of antiallergic drugs in an experimental model of ocular anaphylaxis.","volume":"217","author":"Bayer","year":"2003","journal-title":"Ophthalmologica"},{"key":"R17-12-20210204","doi-asserted-by":"crossref","first-page":"4366","DOI":"10.1167\/iovs.02-1323","article-title":". Ag-specific recognition, activation, and effector function of T cells in the conjunctiva with experimental immune-mediated blepharoconjunctivitis.","volume":"44","author":"Fukushima","year":"2003","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R18-12-20210204","first-page":"2686","article-title":". Topical cyclosporine inhibits mast cell-mediated conjunctivitis.","volume":"37","author":"Whitcup","year":"1996","journal-title":"Invest Ophthalmol Vis Sci"},{"issue":"suppl A","key":"R19-12-20210204","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1016\/0896-8411(92)90031-K","article-title":"The effects of cyclosporin A on non-T cell components of the immune system.","volume":"5","author":"Thomson","year":"1992","journal-title":"J Autoimmun"},{"key":"R20-12-20210204","first-page":"833","article-title":". Comparison between local and systemic administration of cyclosporin a on the effective level in conjunctiva, aqueous humor and serum in German.","volume":"92","author":"Pfau","year":"1995","journal-title":"Ophthalmologe"},{"key":"R21-12-20210204","doi-asserted-by":"crossref","first-page":"68","DOI":"10.1159\/000265417","article-title":". Topically induced ocular anaphylaxis in rats immunized with egg albumin.","volume":"18","author":"Trocme","year":"1986","journal-title":"Ophthalmic Res"},{"key":"R22-12-20210204","first-page":"176","article-title":". Pharmacologic modulation of vascular permeability in ocular allergy in the rat.","volume":"31","author":"Calonge","year":"1990","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R23-12-20210204","doi-asserted-by":"crossref","first-page":"4","DOI":"10.1111\/j.1365-2222.2007.02886.x","article-title":"The mast cell and allergic diseases: role in pathogenesis and implications for therapy.","volume":"38","author":"Brown","year":"2008","journal-title":"Clin Exp Allergy"},{"key":"R24-12-20210204","doi-asserted-by":"crossref","first-page":"325","DOI":"10.1007\/s11882-002-0061-7","article-title":"The central role of conjunctival mast cells in the pathogenesis of ocular allergy.","volume":"2","author":"Leonardi","year":"2002","journal-title":"Curr Allergy Asthma Rep"},{"key":"R25-12-20210204","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1248\/bpb.31.464","article-title":". Effects of multiple dexamethasone treatments on aggravation of allergic conjunctivitis associated with mast cell hyperplasia.","volume":"31","author":"Nagata","year":"2008","journal-title":"Biol Pharm Bull"},{"key":"R26-12-20210204","doi-asserted-by":"crossref","first-page":"1328","DOI":"10.1111\/j.1365-2222.1997.tb01179.x","article-title":". Immunolocalization of cytokines to mast cells in normal and allergic conjunctiva.","volume":"27","author":"Macleod","year":"1997","journal-title":"Clin Exp Allergy"},{"key":"R27-12-20210204","doi-asserted-by":"crossref","first-page":"156","DOI":"10.1016\/S0002-9394(14)70579-3","article-title":"AM, Tabbara KF, Geboes K, et al.. An immunohistochemical study of topical cyclosporine in vernal keratoconjunctivitis.","volume":"121","year":"1996","journal-title":"Am J Ophthalmol"},{"key":"R28-12-20210204","first-page":"392","article-title":". The immunomodulatory effect of topical cyclosporin A in atopic keratoconjunctivitis.","volume":"40","author":"Hingorani","year":"1999","journal-title":"Invest Ophthalmol Vis Sci"},{"key":"R29-12-20210204","doi-asserted-by":"crossref","first-page":"80","DOI":"10.1097\/01.ico.0000133994.22392.47","article-title":". Topical cyclosporine inhibits conjunctival epithelial apoptosis in experimental murine keratoconjunctivitis sicca.","volume":"24","author":"Strong","year":"2005","journal-title":"Cornea"},{"key":"R30-12-20210204","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1159\/000066189","article-title":"Corticosteroids in ophthalmology: past-present-future.","volume":"216","author":"Sherif","year":"2002","journal-title":"Ophthalmologica"},{"key":"R31-12-20210204","doi-asserted-by":"crossref","first-page":"321","DOI":"10.1089\/jop.2009.0009","article-title":". Cyclosporine A eye drops inhibit the early-phase reaction in a type-I allergic conjunctivitis model in mice.","volume":"25","author":"Shii","year":"2009","journal-title":"J Ocul Pharmacol Ther"}],"container-title":["Cornea"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/journals.lww.com\/10.1097\/ICO.0b013e3182a3655d","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,5,18]],"date-time":"2024-05-18T00:34:53Z","timestamp":1715992493000},"score":1,"resource":{"primary":{"URL":"https:\/\/journals.lww.com\/00003226-201311000-00012"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,11]]},"references-count":31,"journal-issue":{"issue":"11","published-print":{"date-parts":[[2013]]}},"URL":"https:\/\/doi.org\/10.1097\/ico.0b013e3182a3655d","relation":{},"ISSN":["0277-3740"],"issn-type":[{"value":"0277-3740","type":"print"}],"subject":[],"published":{"date-parts":[[2013,11]]}}}